VRL Logistics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 26, 2025, 6:27 pm

Competitors of VRL Logistics Ltd

All Competitor Stocks of VRL Logistics Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:15 am

Below is a detailed analysis of the quarterly data for VRL Logistics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 744.00 Cr.. The value appears to be declining and may need further review. It has decreased from 809.00 Cr. (Mar 2025) to 744.00 Cr., marking a decrease of 65.00 Cr..
• For Expenses, as of Jun 2025, the value is 593.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 622.00 Cr. (Mar 2025) to 593.00 Cr., marking a decrease of 29.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 152.00 Cr.. The value appears to be declining and may need further review. It has decreased from 187.00 Cr. (Mar 2025) to 152.00 Cr., marking a decrease of 35.00 Cr..
• For OPM %, as of Jun 2025, the value is 20.00%. The value appears to be declining and may need further review. It has decreased from 23.00% (Mar 2025) to 20.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
• For Depreciation, as of Jun 2025, the value is 65.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 64.00 Cr. (Mar 2025) to 65.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 67.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Mar 2025) to 67.00 Cr., marking a decrease of 33.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 50.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 50.00 Cr., marking a decrease of 24.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.86. The value appears to be declining and may need further review. It has decreased from 4.25 (Mar 2025) to 2.86, marking a decrease of 1.39.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:09 am

Growth

Last Updated: September 5, 2025, 1:51 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for VRL Logistics Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 20.91. This value is within the healthy range. It has increased from 10.16 (Mar 24) to 20.91, marking an increase of 10.75.
• For Diluted EPS (Rs.), as of Mar 25, the value is 20.91. This value is within the healthy range. It has increased from 10.16 (Mar 24) to 20.91, marking an increase of 10.75.
• For Cash EPS (Rs.), as of Mar 25, the value is 49.91. This value is within the healthy range. It has increased from 34.87 (Mar 24) to 49.91, marking an increase of 15.04.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 123.99. It has increased from 108.13 (Mar 24) to 123.99, marking an increase of 15.86.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 123.99. It has increased from 108.13 (Mar 24) to 123.99, marking an increase of 15.86.
• For Dividend / Share (Rs.), as of Mar 25, the value is 15.00. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 24) to 15.00, marking an increase of 15.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 361.38. It has increased from 330.25 (Mar 24) to 361.38, marking an increase of 31.13.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 68.42. This value is within the healthy range. It has increased from 47.39 (Mar 24) to 68.42, marking an increase of 21.03.
• For PBIT / Share (Rs.), as of Mar 25, the value is 39.42. This value is within the healthy range. It has increased from 22.68 (Mar 24) to 39.42, marking an increase of 16.74.
• For PBT / Share (Rs.), as of Mar 25, the value is 28.58. This value is within the healthy range. It has increased from 13.83 (Mar 24) to 28.58, marking an increase of 14.75.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 20.91. This value is within the healthy range. It has increased from 10.16 (Mar 24) to 20.91, marking an increase of 10.75.
• For PBDIT Margin (%), as of Mar 25, the value is 18.93. This value is within the healthy range. It has increased from 14.35 (Mar 24) to 18.93, marking an increase of 4.58.
• For PBIT Margin (%), as of Mar 25, the value is 10.90. This value is within the healthy range. It has increased from 6.86 (Mar 24) to 10.90, marking an increase of 4.04.
• For PBT Margin (%), as of Mar 25, the value is 7.90. This value is below the healthy minimum of 10. It has increased from 4.18 (Mar 24) to 7.90, marking an increase of 3.72.
• For Net Profit Margin (%), as of Mar 25, the value is 5.78. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 5.78, marking an increase of 2.71.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.86. This value is within the healthy range. It has increased from 9.39 (Mar 24) to 16.86, marking an increase of 7.47.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.71. This value is within the healthy range. It has increased from 10.85 (Mar 24) to 15.71, marking an increase of 4.86.
• For Return On Assets (%), as of Mar 25, the value is 7.07. This value is within the healthy range. It has increased from 4.01 (Mar 24) to 7.07, marking an increase of 3.06.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.33. This value is within the healthy range. It has increased from 0.19 (Mar 24) to 0.33, marking an increase of 0.14.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.41. This value is within the healthy range. It has increased from 0.29 (Mar 24) to 0.41, marking an increase of 0.12.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.32. It has decreased from 1.41 (Mar 24) to 1.32, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1.5. It has increased from 0.54 (Mar 24) to 0.64, marking an increase of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 24) to 0.53, marking an increase of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 75.18. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 75.18, marking an increase of 75.18.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 23.90. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 23.90, marking an increase of 23.90.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 10.01. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 10.01, marking an increase of 10.01.
• For Earning Retention Ratio (%), as of Mar 25, the value is 76.10. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 76.10, marking an increase of 76.10.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 89.99. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 89.99, marking an increase of 89.99.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.31. This value is within the healthy range. It has increased from 5.32 (Mar 24) to 6.31, marking an increase of 0.99.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 3. It has increased from 2.14 (Mar 24) to 2.93, marking an increase of 0.79.
• For Enterprise Value (Cr.), as of Mar 25, the value is 4,528.78. It has decreased from 5,039.61 (Mar 24) to 4,528.78, marking a decrease of 510.83.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.43. This value is within the healthy range. It has decreased from 1.74 (Mar 24) to 1.43, marking a decrease of 0.31.
• For EV / EBITDA (X), as of Mar 25, the value is 7.57. This value is within the healthy range. It has decreased from 12.16 (Mar 24) to 7.57, marking a decrease of 4.59.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.31. This value is within the healthy range. It has decreased from 1.65 (Mar 24) to 1.31, marking a decrease of 0.34.
• For Retention Ratios (%), as of Mar 25, the value is 76.09. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 76.09, marking an increase of 76.09.
• For Price / BV (X), as of Mar 25, the value is 3.81. This value exceeds the healthy maximum of 3. It has decreased from 5.05 (Mar 24) to 3.81, marking a decrease of 1.24.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.31. This value is within the healthy range. It has decreased from 1.65 (Mar 24) to 1.31, marking a decrease of 0.34.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.04, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness